Wells Fargo’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Wells Fargo’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-55,538	Closed	-$4.16M	–	6727
2015 Q3	$4.16M	Sell	55,538 -9,936	-15%	-$742K	﹤0.01%	2451
2015 Q2	$4.93M	Buy	65,474 +33,822	+107%	+$1.81M	﹤0.01%	2426
2015 Q1	$1.59M	Buy	31,652 +24,609	+349%	+$1.03M	﹤0.01%	3203
2014 Q4	$244K	Sell	7,043 -967	-12%	-$33.7K	﹤0.01%	4326
2014 Q3	$262K	Sell	8,010 -503	-6%	-$17.7K	﹤0.01%	4229
2014 Q2	$327K	Sell	8,513 -50,606	-86%	-$1.77M	﹤0.01%	4135
2014 Q1	$2.35M	Buy	59,119 +20,421	+53%	+$914K	﹤0.01%	2885
2013 Q4	$1.45M	Buy	38,698 +36,593	+1,738%	+$1.52M	﹤0.01%	3167
2013 Q3	$96K	Buy	+2,105	New	+$63K	﹤0.01%	4483

Wells Fargo's KYTH Position: Q4 2015 in Review

Wells Fargo sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 55,538 shares — an estimated $4.16M sold.

Wells Fargo first reported a position in KYTH in Q3 2013 and held it in 9 quarters. The position peaked at $4.93M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Wells Fargo reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Wells Fargo sold 55,538 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $4.16M.
Wells Fargo first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 9 quarters.
Wells Fargo's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $4.93M in Q2 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Wells Fargo's 13F filing for Q4 2015, filed 9 Feb 2016.